INSTRUCCIONES OFICIALES

Cagrilintide25 mg

Instrucciones originales de producto.

Modelo
M12
Formato
vial liofilizado
Producto
Cagrilintide
Potencia declarada
25 mg

Esta página reúne la documentación oficial disponible para la presentación identificada. Consulte siempre el nombre, el código y el formato del envase.

Documento oficialDocumento original · Inglés

Producto

Cagrilintide

Potencia declarada

25 mg

Modelo

M12

Formato

vial liofilizado

Documento técnico en su idioma original. Se conservan la redacción, las cifras y las advertencias de la documentación oficial.

Original product illustration: cagrilintide-vial-25-mg
Referencia visual incluida en el documento original
Contenido original

Metabolic Care M12

Cagrilintide 25 mg

Lyophilized Vial

This product is a sterile lyophilized powder of cagrilintide supplied in a vial for reconstitution prior to use. It is intended for institutional and professional use.

Sterile powder for reconstitution
For subcutaneous use only

Institutional use only

Composition and Format

  • Active compound: Cagrilintide

  • Total content: 25 mg

  • Form: Sterile lyophilized powder

  • Presentation: Single vial

  • Route of administration: Subcutaneous use

  • Reconstitution volume: 2 ml

  • Concentration after reconstitution: 12.5 mg per 1 ml

Reconstitution Information

The vial contains 25 mg of lyophilized cagrilintide, to be reconstituted with 2 ml of sterile diluent (not included).

After reconstitution:

  • Total volume: 2 ml

  • Concentration: 12.5 mg per 1 ml

Intended Use

This product is intended exclusively for use by licensed institutions and qualified healthcare professionals. It is not intended for direct sale to the public and should be used in accordance with institutional protocols and applicable regulations.

Instructions for Use

  1. Reconstitute the vial with 2 ml of sterile diluent (not included).

  2. Add the diluent slowly along the vial wall.

  3. Swirl gently until the powder is fully dissolved.

  4. Do not shake.

  5. Use only with sterile needles and syringes.

  6. Withdraw the required dose as directed by a healthcare professional.

  7. Do not exceed the recommended dosage.

Storage and Handling

  • Store refrigerated at 2–8 °C.

  • Do not freeze.

  • Protect from light.

  • Protect from inappropriate storage conditions.

  • Do not use the product if storage conditions have not been respected.

Safety Information

  • Refer to the leaflet before use.

  • Do not use this product if the reconstituted solution appears cloudy or contains particles.

  • Do not use if the vial is damaged or compromised.

  • Use only with sterile needles and syringes.

  • Use only as directed by a healthcare professional.

  • Keep out of reach of children.

Regulatory and Disclaimer

This information is provided strictly for institutional and informational purposes only.
True North Labs does not provide medical advice or therapeutic recommendations.
Always follow applicable regulations, institutional protocols, and professional guidance.

Distribution Information

Distributed by: True North Labs

Verifique que el documento corresponda al nombre, código y presentación del etiquetado físico. Esta consulta no es una recomendación médica ni una confirmación de autorizaciones regulatorias.